- Home
- USPH vs OCS Comparison
USPH vs OCS Comparison
Compare USPH & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USPH | OCS |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | Switzerland |
| Employees | 5500 | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | USPH | OCS |
|---|---|---|
| Price | $85.09 | $29.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $106.50 | $39.57 |
| AVG Volume (30 Days) | 194.0K | ★ 303.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ 43.75 | N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | ★ $671,345,000.00 | N/A |
| Revenue This Year | $19.53 | $14.53 |
| Revenue Next Year | $6.33 | $691.13 |
| P/E Ratio | $46.61 | ★ N/A |
| Revenue Growth | ★ 11.00 | N/A |
| 52 Week Low | $62.77 | $14.00 |
| 52 Week High | $93.50 | $29.36 |
Technical Indicators
Market Signals| Indicator | USPH | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 64.14 |
| Support Level | $84.37 | $28.05 |
| Resistance Level | $90.94 | $29.09 |
| Average True Range (ATR) | 2.78 | 1.01 |
| MACD | -0.05 | -0.22 |
| Stochastic Oscillator | 45.48 | 76.12 |
Price Performance
Historical ComparisonAbout USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.